Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / Common Stock, $0.0001 Par Value Per Share
-
Shares outstanding
-
107,800,271
-
Total 13F shares
-
18,074,357
-
Share change
-
+1,018,879
-
Total reported value
-
$577,471,946
-
Put/Call ratio
-
54%
-
Price per share
-
$31.95
-
Number of holders
-
91
-
Value change
-
+$34,573,785
-
Number of buys
-
60
-
Number of sells
-
25
Institutional Holders of Intra-Cellular Therapies, Inc. - Common Stock, $0.0001 Par Value Per Share (ITCI) as of Q2 2015
As of 30 Jun 2015,
Intra-Cellular Therapies, Inc. - Common Stock, $0.0001 Par Value Per Share (ITCI) was held by
91 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,074,357 shares.
The largest 10 holders included
FMR LLC, WASATCH ADVISORS INC, Visium Asset Management, LP, BlackRock Fund Advisors, VANGUARD GROUP INC, BlackRock Advisors LLC, ADAGE CAPITAL PARTNERS GP LLC, Redmile Group, LLC, BlackRock Institutional Trust Company, N.A., and MILLENNIUM MANAGEMENT LLC.
This page lists
91
institutional shareholders reporting positions in this security
for the Q2 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.